polivy powder for concentrate for solution for infusion 140mg
roche singapore pte. ltd. - polatuzumab vedotin - injection, powder, lyophilized, for solution - polatuzumab vedotin 140 mg
polivy powder for concentrate for solution for infusion 30mg
roche singapore pte. ltd. - polatuzumab vedotin - injection, powder, lyophilized, for solution - polatuzumab vedotin 30mg/vial
polivy
roche registration gmbh - polatuzumab vedotin - lymphoma, b-cell - antineoplastic agents - polivy in combination with bendamustine and rituximab is indicated for the treatment of adult patients with relapsed/refractory diffuse large b-cell lymphoma (dlbcl) who are not candidates for haematopoietic stem cell transplant.polivy in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (r-chp) is indicated for the treatment of adult patients with previously untreated diffuse large b-cell lymphoma (dlbcl).
polivy powder for solution
hoffmann-la roche limited - polatuzumab vedotin - powder for solution - 140mg - polatuzumab vedotin 140mg - antineoplastic agents
polivy powder for solution
hoffmann-la roche limited - polatuzumab vedotin - powder for solution - 30mg - polatuzumab vedotin 30mg - antineoplastic agents
polivy 140mg powder for concentrate for solution for infusion 140 mg/1 vil
مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - polatuzumab vedotin 140 mg/1 vil - 140 mg/1 vil